|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||3.2422 - 3.2542|
|52 Week Range||0.7000 - 3.8200|
|PE Ratio (TTM)||-5.89|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The members of congress introduced a bill related to the talk last week. A quartet of Democratic members of Congress introduced a bill last week in harmony with President Donald Trump’s campaign promises of lowering prescription drug costs. Entitled the Improving Access to Affordable Prescription Drugs Act, the 128-page bill aims to overhaul what many view as a broken system that has seen bipartisan outrage over skyrocketing prices.
Novogen Ltd (NASDAQ: NVGN ) is pleased to confirm receipt of $4.4m from the Australian Taxation Office under the R&D Tax Incentive Program for the financial year ending 30 June 2016. These funds will be ...
Novogen Ltd (NASDAQ: NVGN ) today announced that it has entered into a worldwide licensing agreement with Genentech, a member of the Roche Group (OTC: RHHBY ), to develop and commercialise GDC-0084, a ...